Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12110283 Carbonic anhydrase targeting agents and methods of using same

Patent 12110283 was granted and assigned to VisEn Medical on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kevin Groves0

Bagna Bao0

Date of Patent

October 8, 2024

0

Patent Application Number

173720290

Date Filed

July 9, 2021

0

Patent Citations

US Patent 7439319 Selective substrates for matrix metalloproteinases

0

US Patent 7445767 In-vivo diagnostic method by near infrared radiation

0

US Patent 7647091 Method and system for free space optical tomography of diffuse media

0

US Patent 7655217 Near infrared imaging agent

0

US Patent 7833737 CA IX-specific inhibitors

0

US Patent 7947256 Biocompatible fluorescent imaging agents

0

US Patent 7962200 Method and system for free space optical tomography of diffuse media

0

US Patent 6869593 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

The invention provides agents that target carbonic anhydrase, which can be used as imaging agents or therapeutic agents. The agents can be used to image tumor hypoxia as well as other physiological processes in a subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12110283 Carbonic anhydrase targeting agents and methods of using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool